Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

被引:238
作者
Evans, Rachael A. [1 ]
Leavy, Olivia C. [1 ]
Richardson, Matthew [1 ]
Elneima, Omer [1 ]
McAuley, Hamish J. C. [1 ]
Shikotra, Aarti [1 ]
Singapuri, Amisha [1 ]
Sereno, Marco [1 ]
Saunders, Ruth M. [1 ]
Harris, Victoria C. [1 ]
Aul, Raminder [1 ]
Beirne, Paul [1 ]
Bolton, Charlotte E. [1 ]
Brown, Jeremy S. [1 ]
Choudhury, Gourab [1 ]
Bakerly, Nawar Diar [1 ]
Easom, Nicholas [1 ]
Echevarria, Carlos [1 ]
Fuld, Jonathan [1 ]
Hart, Nick [1 ]
Hurst, John R. [1 ]
Jones, Mark [1 ]
Parekh, Dhruv [1 ]
Pfeffer, Paul [1 ]
Rahman, Najib M. [1 ]
Rowland-Jones, Sarah [1 ]
Shah, Ajay M. [1 ]
Wootton, Dan G. [1 ]
Chalder, Trudie [1 ]
Davies, Melanie J. [1 ]
De Soyza, Anthony [1 ]
Greenhalf, William [1 ]
Greening, Neil J. [1 ]
Heaney, Liam G. [1 ]
Heller, Simon [1 ]
Howard, Luke [1 ]
Jacob, Joseph [1 ]
Jenkins, R. Gisli [1 ]
Lord, Janet M. [1 ]
Man, Will D-C [1 ]
McCann, Gerry P. [1 ]
Neubauer, Stefan [1 ]
Openshaw, Peter J. M. [1 ]
Porter, Joanna [1 ]
Quint, Jennifer [1 ]
Rowland, Matthew J. [1 ]
Scott, Janet T. [1 ]
Semple, Malcolm G. [1 ]
Singh, Sally J. [1 ]
Toshner, Mark [1 ]
机构
[1] Univ Leicester, Natl Inst Hlth Res Leicester, Dept Resp Sci, Biomed Res Ctr,Inst Lung Hlth, Leicester LE3 9QP, Leics, England
基金
英国科研创新办公室;
关键词
D O I
10.1016/S2213-2600(22)00127-8
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background No effective pharmacological or non-pharmacological interventions exist for patients with long COVID. We aimed to describe recovery 1 year after hospital discharge for COVID-19, identify factors associated with patient-perceived recovery, and identify potential therapeutic targets by describing the underlying inflammatory profiles of the previously described recovery clusters at 5 months after hospital discharge. Methods The Post-hospitalisation COVID-19 study (PHOSP-COVID) is a prospective, longitudinal cohort study recruiting adults (aged >= 18 years) discharged from hospital with COVID-19 across the UK. Recovery was assessed using patient-reported outcome measures, physical performance, and organ function at 5 months and 1 year after hospital discharge, and stratified by both patient-perceived recovery and recovery cluster. Hierarchical logistic regression modelling was performed for patient-perceived recovery at 1 year. Cluster analysis was done using the clustering large applications k-medoids approach using clinical outcomes at 5 months. Inflammatory protein profiling was analysed from plasma at the 5-month visit. This study is registered on the ISRCTN Registry ISRCTN10980107, and recruitment is ongoing. Findings 2320 participants discharged from hospital between March 7,2020, and April 18, 2021, were assessed at 5 months after discharge and 807 (32.7%) participants completed both the 5-month and 1-year visits. 279 (35.6%) of these 807 patients were women and 505 (64.4%) were men, with a mean age of 58.7 (SD 12.5) years, and 224 (27.8%) had received invasive mechanical ventilation (WHO class 7-9). The proportion of patients reporting full recovery was unchanged between 5 months (501 [25.5%1 of 1965) and 1 year (232 128.9%1 of 804). Factors associated with being less likely to report full recovery at 1 year were female sex (odds ratio 0.68 [95% CI 0.46-0-99)), obesity (0.50 [0.34-0.74]) and invasive mechanical ventilation (0.42 [0-23-0-76]). Cluster analysis (n=1636) corroborated the previously reported four clusters: very severe, severe, moderate with cognitive impairment, and mild, relating to the severity of physical health, mental health, and cognitive impairment at 5 months. We found increased inflammatory mediators of tissue damage and repair in both the very severe and the moderate with cognitive impairment clusters compared with the mild cluster, including IL-6 concentration, which was increased in both comparisons (n=626 participants). We found a substantial deficit in median EQ-5D-5L utility index from before COVID-19 (retrospective assessment; 0.88 [IQR 0.74-1.00J), at 5 months (0.74 [0.64-0-881) to 1 year (0.75 [0- 62-0- 881), with minimal improvements across all outcome measures at 1 year after discharge in the whole cohort and within each of the four clusters. Interpretation The sequelae of a hospital admission with COVID-19 were substantial 1 year after discharge across a range of health domains, with the minority in our cohort feeling fully recovered. Patient-perceived health-related quality of life was reduced at 1 year compared with before hospital admission. Systematic inflammation and obesity are potential treatable traits that warrant further investigation in clinical trials. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
引用
收藏
页码:761 / 775
页数:15
相关论文
共 38 条
  • [1] [Anonymous], 2018, Lancet Infectious Diseases, V18, P1191
  • [2] Long COVID in a prospective cohort of home-isolated patients
    Blomberg, Bjorn
    Mohn, Kristin Greve-Isdahl
    Brokstad, Karl Albert
    Zhou, Fan
    Linchausen, Dagrun Waag
    Hansen, Bent-Are
    Lartey, Sarah
    Onyango, Therese Bredholt
    Kuwelker, Kanika
    Saevik, Marianne
    Bartsch, Hauke
    Tondel, Camilla
    Kittang, Bard Reiakvam
    Cox, Rebecca Jane
    Langeland, Nina
    [J]. NATURE MEDICINE, 2021, 27 (09) : 1607 - +
  • [3] Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19)
    Boscolo-Rizzo, Paolo
    Guida, Francesco
    Polesel, Jerry
    Marcuzzo, Alberto Vito
    Capriotti, Vincenzo
    D'Alessandro, Andrea
    Zanelli, Enrico
    Marzolino, Riccardo
    Lazzarin, Chiara
    Antonucci, Paolo
    Sacchet, Erica
    Tofanelli, Margherita
    Borsetto, Daniele
    Gardenal, Nicoletta
    Pengo, Martino
    Tirelli, Giancarlo
    [J]. INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2021, 11 (12) : 1685 - 1688
  • [4] CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis
    Dhaeze, Tessa
    Tremblay, Laurence
    Lachance, Catherine
    Peelen, Evelyn
    Zandee, Stephanie
    Grasmuck, Camille
    Bourbonniere, Lyne
    Larouche, Sandra
    Ayrignac, Xavier
    Rebillard, Rose-Marie
    Poirier, Josee
    Lahav, Boaz
    Duquette, Pierre
    Girard, Marc
    Moumdjian, Robert
    Bouthillier, Alain
    Larochelle, Catherine
    Prat, Alexandre
    [J]. CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (07) : 652 - 665
  • [5] Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
    Docherty, Annemarie
    Mulholland, Rachel
    Lone, Nazir, I
    Cheyne, Christopher
    De Angelis, Daniela
    Diaz-Ordaz, Karla
    Donegan, Cara
    Drake, Thomas
    Dunning, Jake
    Funk, Sebastian
    Garcia-Finana, Marta
    Girvan, Michelle
    Hardwick, Hayley
    Harrison, Janet
    Ho, Antonia
    Hughes, David
    Keogh, Ruth
    Kirwan, Peter
    Leeming, Gary
    Van-Tam, Jonathan
    Pius, Riinu
    Russell, Clark
    Spencer, Rebecca
    Tom, Brian
    Turtle, Lance
    Openshaw, Peter
    Baillie, J.
    Harrison, Ewen
    Semple, Malcolm
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (07) : 773 - 785
  • [6] Quality of life after acute respiratory distress syndrome: a meta-analysis
    Dowdy, David W.
    Eid, Mark P.
    Dennison, Cheryl R.
    Mendez-Tellez, Pedro A.
    Herridge, Margaret S.
    Guallar, Eliseo
    Pronovost, Peter J.
    Needham, Dale M.
    [J]. INTENSIVE CARE MEDICINE, 2006, 32 (08) : 1115 - 1124
  • [7] Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study
    Evans, Rachael A.
    McAuley, Hamish
    Harrison, Ewen M.
    Shikotra, Aarti
    Singapuri, Amisha
    Sereno, Marco
    Elneima, Omer
    Docherty, Annemarie B.
    Lone, Nazir, I
    Leavy, Olivia C.
    Daines, Luke
    Baillie, J. Kenneth
    Brown, Jeremy S.
    Chalder, Trudie
    De Soyza, Anthony
    Bakerly, Nawar Diar
    Easom, Nicholas
    Geddes, John R.
    Greening, Neil J.
    Hart, Nick
    Heaney, Liam G.
    Heller, Simon
    Howard, Luke
    Hurst, John R.
    Jacob, Joseph
    Jenkins, R. Gisli
    Jolley, Caroline
    Kerr, Steven
    Kon, Onn M.
    Lewis, Keir
    Lord, Janet M.
    McCann, Gerry P.
    Neubauer, Stefan
    Openshaw, Peter J. M.
    Parekh, Dhruv
    Pfeffer, Paul
    Rahman, Najib M.
    Raman, Betty
    Richardson, Matthew
    Rowland, Matthew
    Semple, Malcolm G.
    Shah, Ajay M.
    Singh, Sally J.
    Sheikh, Aziz
    Thomas, David
    Toshner, Mark
    Chalmers, James D.
    Ho, Ling-Pei
    Horsley, Alex
    Marks, Michael
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (11) : 1275 - 1287
  • [8] Minimum important difference of the incremental shuttle walk test distance in patients with COPD
    Evans, Rachael A.
    Singh, Sally J.
    [J]. THORAX, 2019, 74 (10) : 994 - 995
  • [9] Prevalence of Post-COVID-19 Cough One Year After SARS-CoV-2 Infection: A Multicenter Study
    Fernandez-de-las-Penas, Cesar
    Guijarro, Carlos
    Plaza-Canteli, Susana
    Hernandez-Barrera, Valentin
    Torres-Macho, Juan
    [J]. LUNG, 2021, 199 (03) : 249 - 253
  • [10] Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions
    Filbin, Michael R.
    Mehta, Arnav
    Schneider, Alexis M.
    Kays, Kyle R.
    Guess, Jamey R.
    Gentili, Matteo
    Fenyves, Bank G.
    Charland, Nicole C.
    Gonye, Anna L. K.
    Gushterova, Irena
    Khanna, Hargun K.
    LaSalle, Thomas J.
    Lavin-Parsons, Kendall M.
    Lilley, Brendan M.
    Lodenstein, Carl L.
    Manakongtreecheep, Kasidet
    Margolin, Justin D.
    McKaig, Brenna N.
    Rojas-Lopez, Maricarmen
    Russo, Brian C.
    Sharma, Nihaarika
    Tantivit, Jessica
    Thomas, Molly F.
    Gerszten, Robert E.
    Heimberg, Graham S.
    Hoover, Paul J.
    Lieb, David J.
    Lin, Brian
    Ngo, Debby
    Pelka, Karin
    Reyes, Miguel
    Smillie, Christopher S.
    Waghray, Avinash
    Wood, Thomas E.
    Zajac, Amanda S.
    Jennings, Lori L.
    Grundberg, Ida
    Bhattacharyya, Roby P.
    Parry, Blair Alden
    Villani, Alexandra-Chloe
    Sade-Feldman, Moshe
    Hacohen, Nir
    Goldberg, Marcia B.
    [J]. CELL REPORTS MEDICINE, 2021, 2 (05)